Stella Diagnostics, Inc. — Regulation A 1-A/A
Stella Diagnostics, Inc. of Salt Lake City, UT filed a Regulation A 1-A/A with the SEC on 2021-05-10. Aggregate offering: $20.0M (Tier 1). Industry: Other.
Offering
- Filed: 2021-05-10
- Form: 1-A/A
- Accession: 0001477932-21-002980
- Tier: Tier 1
- Total aggregate offering: $20.0M
- Issuer portion: $15.4M
- Selling securityholders: $4.6M
- Price per security: $5.0000
- Securities offered: Equity (common or preferred stock)
- Broker-dealer CRD: 136352
- Audit status: Unaudited
- Jurisdictions: 63 states/territories
Issuer
- CIK: 0001827620
- Organized in: WY
- Incorporated: 1992
- Address: 50 West Broadway, Suite 300, Salt Lake City, UT, 84101
- Phone: 201-381-1474
- Employees: 1 full-time, 3 part-time
Financial snapshot (as filed)
- Total assets: $40K
- Cash & equivalents: $37K
- Total liabilities: $10.6M
- Stockholder equity: $-10.5M
- Net income: $-262K
People (3)
| Name | Role | Location |
|---|
| Jonathan Leinwand | Signer | Fort Lauderdale, FL |
| Matthew Mcmurdo | Signer | Los Angeles, CA |
| Clint Foss | Signer | Salt Lake City, UT |
Other Reg A filings by this issuer (4)
More